Back

Choose your region

Europe:

Flag Albania Albania Flag Bosnia and Herzegovina Bosnia and Herzegovina Flag Bulgaria Bulgaria Flag Croatia Croatia Flag Czechia Czechia Flag Cyprus Cyprus Flag Denmark Denmark Flag Estonia Estonia Flag Germany Germany Flag Hungary Hungary Flag Italy Italy Flag Kosowo Kosowo Flag Latvia Latvia Flag Lithuania Lithuania Flag Luxembourg Luxembourg Flag Macedonia Macedonia Flag Montenegro Montenegro Flag Poland Poland Flag Portugal Portugal Flag Romania Romania Flag Serbia Serbia Flag Slovakia Slovakia Flag Slovenia Slovenia Flag Spain Spain Flag Sweden Sweden Flag Switzerland Switzerland Flag Turkey Turkey Flag United Kingdom United Kingdom

Asia:

Flag Hong Kong Hong Kong Flag Kuwait Kuwait Flag Lebanon Lebanon Flag UAE UAE

Africa:

Flag RSA RSA

Expansion of FamiCord activity to Balkans

FamiCord Group offers its services to families mostly in a B2C model where FamiCord subsidiary has
direct contractual relationships with family to collect and store cord blood stem cells. The other
model which is present in the market is B2B partnership, where 3 rd Party subcontracts FamiCord to
perform the services. In such situation Partner contractual responsibility to the client is to collect
cord blood and organize logistic to FamiCord to do processing, testing and storage of stem cells.

Recently FamiCord established new partnership with leading company from
the sector in Balkan countries – BioSave Group. Based on that partnership – cord
blood banking services provided by FamiCord will be offered to BioSave clients in Serbia,
Montenegro, Bosnia&Herzegovina, Slovenia and Macedonia as well as other markets in the region.

Recently added

  • FamiCord Group Recognized as Europe’s Leading Stem Cell Bank FamiCord is the largest stem cell bank in Europe and the third largest in the world. The quality of its services is validated by international certifications, and the company has now been recognized as Europe’s Leading Stem Cell Bank by Life Sciences Review, highlighting its commitment to excellence, clinical reliability, and innovation in stem cell banking.FamiCord Group have been awarded as “The Europe’s Leading Stem Cell Bank” , independent experts jury underlined FamiCord has established itself as a leading provider in the field, guiding families through the collection, processing, and long-term preservation of cord blood and perinatal tissues. Read more
  • Infantile cerebral palsy – Convincing evidence for the use of perinatal stem cells Leipzig, July 15, 2025 - Cerebral palsy (CP) continues to be one of the most common motor disabilities in childhood and is associated with permanent movement restrictions and spasticity. The therapeutic potential of stem cells from umbilical cord blood and tissue was discussed at the 37th Annual Meeting of the European Academy Of Childhood-onset Disabilities (EACD) and the 4th Meeting of the International Alliance of Academies of C hildhood Disability (IAACD) from June 24 - 28, 2025 in Heidelberg. As part of a symposium supported by FamiCord AG, international experts presented the current state of research and reported on the results from clinical practice. Read more